Johnson & Johnson on Monday announced a $3.1 billion deal to buy privately-held cancer biotech Halda Therapeutics, the latest in a cavalcade of biotech acquisitions as the sector has heated up over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback